CLDN3 and hepatocellular carcinoma: A significantly higher expression of HDACs have already been previously observed in HCC tumors compared to normal tissues, and their pharmacological inhibition resulted in inhibition of metastasis and invasion in HCC via upregulation of early growth response gene-1 and claudin-3 (72).